A study on the adaptation of the HIV/AIDS‐related Stigma Scale into Turkish

Bahar, Zühal; Çal, Ayşe; Beşer, Ayşe; Çavuşoğlu, Figen; Deveci, Aydın; Badur, Selim; Bahar, I. Hakkı

doi:10.1111/ppc.12984

Cited by 4 publications

(5 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The CFA results for the two-factor model indicated the model was a good fit: SRMR=0.038<0.05, RMSEA=0.12<1.0, GFI=0.912>0.800, NFI=0.883>0.800, TLI=0.845>0.800, CFI=0.888>0.850. 42–44 Furthermore, although there is a positive correlation between these two dimensions, they represent distinct facets of stigma and may be considered independent. This finding provides further evidence for the necessity of analyzing these two dimensions separately ( Figure 2 ).…”

Section: Resultsmentioning

confidence: 99%

“…[38][39][40][41] The critical values for acceptable model fit used in the present study were SRMR<0.08, RMSEA≤1.0, GFI≥0.80, NFI≥0.80, TLI≥0.80, CFI≥0.85. [42][43][44] Composite Reliability (CR), Average Variance Extracted (AVE) and Heterotrait-Monotrait ratio (HTMT) values of scale were calculated to test convergent and divergent validity.…”

Section: Discussionmentioning

confidence: 99%

Section: Confirmatory Factor Analysis (Cfa)mentioning

confidence: 98%

See 2 more Smart Citations

Psychometric Characteristics of the Chinese Version of the Tuberculosis Related-Stigma Scale in a Population of Medical Students and Its Correlation with Selected Demographic Characteristics

Yi,

Sun,

et al. 2024

RMHP

View full text Add to dashboard Cite

Background As future health workers, medical students’ attitudes towards tuberculosis (TB) patients can impact TB control. However, in China, there is a lack of well-quantified assessment regarding the stigma among medical students towards TB patients. Therefore, this study aimed to validate the Chinese version of the Tuberculosis related-Stigma Scale (TSS) in medical students and to apply the scale to measure stigma and its determinants. Methods A total of 1035 eligible medical students participated in the cross-sectional questionnaire. Exploratory factor analyses (EFA) and confirmatory factor analyses (CFA) were first conducted to test Chinese version of the TSS construct validity, and then internal consistency was assessed using Cronbach’s α. Finally, multiple linear regression analyses were conducted to identify predictors of stigma. Results EFA extracted two factors (“Social distance” and “Exclusionary sentiments”). The CFA further confirmed the two-factor construct. The internal consistency, convergent and divergent validity of the adapted Chinese version of the TSS was acceptable. Furthermore, Whether one has received TB health education and whether know a person with TB are associated with all dimensions of TB stigma, while differences in sex and place of residence play different roles in influencing the different dimensions of stigma. Conclusion The adapted Chinese version of the TSS can be used to assess the level of stigma among medical students in China towards tuberculosis patients. When implementing future interventions to reduce stigma associated with TB, special attention should be given to medical students from urban areas, of male gender, who have not received TB health education, and no know a person with TB. However, these two dimensions (“Social distance” and “Exclusionary sentiments”) are impacted by different determinants and should therefore be addressed separately when designing, implementing, and evaluating measures to reduce stigma.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Psychometric Characteristics of the Chinese Version of the Tuberculosis Related-Stigma Scale in a Population of Medical Students and Its Correlation with Selected Demographic Characteristics

Yi,

Sun,

et al. 2024

RMHP

View full text Add to dashboard Cite

show abstract

“…Regarding model fit, the values are considered as follows; χ ²/df <3 perfect fit, RMSEA 0.08 and below good fit, CFI 0.90 and above good fit, NFI and CFI 0.95 and above perfect fit, IFI 0.90 and above good fit, GFI 0.90 and above good fit (Bahar and Cal, 2022). Coelho et al (2021) reported the following fit indices for the original scale: GFI = 0.96, CFI = 0.98 and RMSEA = 0.08.…”

Section: Discussionmentioning

confidence: 99%

Psychometric properties of the Turkish version of the therapeutic relationship assessment scale for nurses

Duran,

Polat

2023

Journal of Research in Nursing

View full text Add to dashboard Cite

Background: It is essential for nurses who care for individuals diagnosed with mental illness to establish a therapeutic relationship. There is no measurement tool available in Türkiye to assess the therapeutic relationship between patient and nurse. Aim: The objective of this study is to perform a validity and reliability study of the Turkish version of a scale that enables the evaluation of the quality of the therapeutic relationship established between nurses and patients. Methods: 140 nurses were included in this study. The data were analysed using the exploratory and confirmatory analyses. Results: The scale consists of 25 items and four sub-dimensions. In confirmatory factor analysis (CFA), all factor loads were >0.30. As a result of CFA, all fit indices were >0.85 and the root mean square approximation was <0.080. Cronbach alpha was 0.93 for the whole scale. Conclusion: The Turkish version of the TRAS-Nurse scale and its original version were compatible with each other and gave similar results. This scale can be used to determine the therapeutic relationship of nurses who care for psychiatric patients in Türkiye and can be a useful measurement tool when evaluating the factors that may be effective in improving the therapeutic relationship.

show abstract

“…Monitoring the effectiveness of HIV stigma-reducing interventions using validated measures can support local programmes advocating for additional resources and enable the identification and sharing of best practice. The HIV Stigma Scale is a reliable and validated measure of HIV-related stigma [ 57 ], which could be adapted for use in CEE in the same way that it has been in Turkey [ 58 , 59 ], Ukraine [ 29 ], and Japan [ 60 ]. An adapted HIV Stigma Scale to monitor stigma related to pre-exposure prophylaxis use has also been developed [ 61 ].…”

Section: Discussionmentioning

confidence: 99%

Addressing HIV stigma in healthcare, community, and legislative settings in Central and Eastern Europe

Schweitzer,

Dišković,

Krongauz

et al. 2023

AIDS Res Ther

View full text Add to dashboard Cite

Introduction Surging HIV prevalence across countries of Central and Eastern Europe (CEE) is largely a result of poor HIV care engagement and a lack of comprehensive support for key populations. This is fostered by widespread stigma across healthcare, community, and legislative settings. Discussion Throughout CEE, HIV stigma and intersectional stigma are serious obstacles to providing adequate medical care to people living with HIV. Anticipated and enacted (experienced) stigma from healthcare professionals, and fears of breaches in confidentiality, deter individuals from having an HIV test and engaging in HIV care. Furthermore, negative connotations surrounding HIV infection can lead to discrimination from family, friends, colleagues, and the public, leading to internalized stigma and depression. Key populations that have higher HIV prevalence, such as men who have sex with men, people who inject drugs, transgender individuals, and sex workers, experience additional stigma and discrimination based on their behaviour and identities. This contributes to the concentrated HIV epidemics seen in these populations in many CEE countries. The stigma is exacerbated by punitive legislation that criminalizes HIV transmission and penalizes sexual orientation, drug use, gender identities, and sex work. Despite high levels of HIV stigma and intersectional stigma, there are many evidence-based interventions that have reduced stigma in other parts of the world. Here, we discuss the interventions that are currently being enacted in various countries of CEE, and we suggest additional effective, evidence-based interventions that will tackle stigma and lead to increased HIV care engagement and higher rates of viral suppression. We cover the promotion of the undetectable = untransmittable (U = U) message, stigma-reduction education and training for healthcare professionals, patient-centric approaches for testing and treatment, and advocacy for non-discriminatory legislation, policies, and practices. We also consider targeted stigma-reduction interventions that acknowledge the wider challenges faced by marginalized populations. Conclusions HIV stigma and intersectional stigma in CEE drive poor engagement with HIV testing services and care. Widespread adoption of evidence-based interventions to tackle stigma highlighted in this review will improve the quality of life of people living with HIV, improve HIV care engagement, and ultimately slow the surging HIV prevalence and concentrated epidemics occurring throughout CEE.

show abstract

A study on the adaptation of the HIV/AIDS‐related Stigma Scale into Turkish

Cited by 4 publications

References 28 publications

Psychometric Characteristics of the Chinese Version of the Tuberculosis Related-Stigma Scale in a Population of Medical Students and Its Correlation with Selected Demographic Characteristics

Psychometric Characteristics of the Chinese Version of the Tuberculosis Related-Stigma Scale in a Population of Medical Students and Its Correlation with Selected Demographic Characteristics

Psychometric properties of the Turkish version of the therapeutic relationship assessment scale for nurses

Addressing HIV stigma in healthcare, community, and legislative settings in Central and Eastern Europe

Contact Info

Product

Resources

About